Manufacturing

Jennifer Markarian is manufacturing reporter for Pharmaceutical Technology.

Articles

Collaboration and new tools aid efforts to implement new processing technologies for small-molecule drug product manufacturing.

Breaking Through Barriers to Continuous Manufacturing

Anand Rajan is head of Sales, ACG Engineering, anand.rajan@acg-world.com.

Smart manufacturing transforms management of tablet and capsule equipment and processes.

Troubleshooting Using Predictive Maintenance

CDMOs offer expertise and capacity for spray drying.

Spray Drying Finds Growing Use for ASDs

CordenPharma will build a clinical trial development facility for manufacture of oral solid dosage drug products at its Plankstadt facility near Heidelberg, Germany.

CordenPharma Adds Highly Potent Capabilities in Germany

Gernot Warnke, Head of R&D, JRS Pharma, spoke about excipients and how these relate to feeding in batch and continuous manufacturing. 

Equipment Trends in Advanced Solid-Dosage Drug Manufacturing: INTERPHEX Keynote Part 5

Sharon Nowak, Business Development Manager, Coperion K-Tron USA Food & Pharmaceutical Industries spoke about feeding equipment in solid-dosage drug manufacturing.

Equipment Trends in Advanced Solid-Dosage Drug Manufacturing: INTERPHEX Keynote Part 4

Fernando Muzzio, PhD, Distinguished Professor of Chemical and Biochemical Engineering at Rutgers University, spoke about trends in continuous manufacturing of OSD drugs.

Equipment Trends in Advanced Solid-Dosage Drug Manufacturing: INTERPHEX Keynote Part 3

Johannes Khinast, PhD, Institute for Process and Particle Engineering in the Research Center Pharmaceutical Engineering (RCPE) at the Graz University of Technology in Austria, spoke about continuous manufacturing of OSD drugs.

Equipment Trends in Advanced Solid-Dosage Drug Manufacturing: INTERPHEX Keynote Part 2

Evolving equipment designs meet the unique needs of continuous processing techniques.

Adopting Continuous Manufacturing for Solid-Dose Drug Products

The companies collaborate to develop and commercialize ARV-471, an investigational oral PROTAC (proteolysis targeting chimeras) estrogen receptor protein degrader.

Manufacturing, Solid Dosage Drugs